Shire offers €428 million for GI specialist Movetis
This article was originally published in Scrip
Executive Summary
Shire is expanding its gastrointestinal portfolio and pipeline, while widening its geographical reach outside the US market, with a recommended €428 million takeover offer for Belgian specialty company Movetis.